BerandaMNKD • NASDAQ
add
MannKind Corp
Tutup sebelumnya
$3,77
Rentang hari
$3,68 - $3,78
Rentang tahun
$3,63 - $7,62
Kapitalisasi pasar
1,14Â M USD
Volume Rata-Rata
2,54Â jt
Rasio P/E
38,25
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 78,35Â jt | 18,25% |
Biaya operasional | 36,04Â jt | 11,42% |
Laba bersih | 13,16Â jt | 23,78% |
Margin laba bersih | 16,79 | 4,68% |
Penghasilan per saham | 0,04 | — |
EBITDA | 26,91Â jt | 62,11% |
Tarif pajak efektif | 3,37% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 188,04Â jt | -38,87% |
Total aset | 410,14Â jt | -14,71% |
Total liabilitas | 468,76Â jt | -34,06% |
Total ekuitas | -58,62 jt | — |
Saham yang beredar | 303,93 jt | — |
Harga terhadap nilai buku | -19,84 | — |
Tingkat pengembalian aset | 15,42% | — |
Tingkat pengembalian modal | 72,93% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 13,16Â jt | 23,78% |
Kas dari operasi | -6,38Â jt | -195,14% |
Kas dari investasi | 5,96Â jt | 112,31% |
Kas dari pembiayaan | 1,39Â jt | 140,01% |
Perubahan kas bersih | 975,00Â rb | 102,16% |
Arus kas bebas | -6,30Â jt | -470,51% |
Tentang
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Didirikan
Feb 1991
Kantor pusat
Situs
Karyawan
405
